Financial
FY2026 revenue $36.36bn (+8.4%); operating margin 17.8%; net income $4.80bn.
Balance sheet figures not captured from release.
Medtronic
HQ Ireland · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Strong
Customer rating
No reviews yet
Financial health
Band: StrongListed: MDT
FY2026 revenue $36.36bn (+8.4%); operating margin 17.8%; net income $4.80bn.
Balance sheet figures not captured from release.
Source: official results release · Year ended 2026-04-24 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2026 | US$36.4bn | +8.4% | US$6.5bn | US$4.8bn | Medtronic |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Mar 2026: Medtronic completed the carve-out of its diabetes business, MiniMed Group, which listed separately on Nasdaq.
Cyber & information governance
Apr 2026: Medtronic disclosed a breach of its corporate IT systems after the ShinyHunters group claimed to hold over 9 million records; Medtronic said products, patient safety and manufacturing were not affected. Several proposed class actions followed. NHS DSPT status not yet checked.
Regulatory & clinical safety
Oct 2025: the FDA classed Medtronic's recall of DLP left heart vent catheters as Class I after 41 complaints that catheters may not hold their shape when bent; Medtronic said no deaths had been reported.
Contract performance
Dec 2025: Medtronic was named one of eight suppliers on NHS Supply Chain's managed services framework lot for angiography equipment and accessories (lot value £399.5m ex VAT across all suppliers).
Competitors
No competitors linked yet.